| NK cells in chronic lymphocytic leukemia and their therapeutic implications P Sportoletti, F De Falco, B Del Papa, S Baldoni, V Guarente, A Marra, ... International Journal of Molecular Sciences 22 (13), 6665, 2021 | 19 | 2021 |
| GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations P Sportoletti, L Celani, E Varasano, R Rossi, D Sorcini, C Rompietti, ... Leukemia 33 (7), 1827-1832, 2019 | 18 | 2019 |
| Lessons, Challenges and future therapeutic opportunities for PI3K inhibition in CLL V Guarente, P Sportoletti Cancers 13 (6), 1280, 2021 | 17 | 2021 |
| Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib FR Mauro, D Giannarelli, A Visentin, G Reda, P Sportoletti, AM Frustaci, ... Cancers 13 (13), 3240, 2021 | 16 | 2021 |
| Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice P Sportoletti, D Sorcini, AG Guzman, JM Reyes, A Stella, A Marra, ... Leukemia 35 (7), 1949-1963, 2021 | 13 | 2021 |
| Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model S Molica, D Giannarelli, A Visentin, G Reda, P Sportoletti, AM Frustaci, ... American Journal of Hematology 97 (5), E176-E180, 2022 | 6 | 2022 |
| NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status S Baldoni, B Del Papa, F De Falco, E Dorillo, C Sorrentino, C Rompietti, ... Frontiers in Oncology 11, 668573, 2021 | 5 | 2021 |
| Role of age, fitness and concomitant medications in CLL patients treated with venetoclax AM Frustaci, A Biagi, A Chiarenza, M Coscia, S Ciolli, L Laurenti, ... Blood 136, 25-26, 2020 | 4 | 2020 |
| Immune correlates of protection by vaccine against SARS‐CoV‐2 in patients with chronic lymphocytic leukaemia D Sorcini, F De Falco, M Gargaro, S Bozza, V Guarente, V Cardinali, ... British Journal of Haematology 201 (1), 45-57, 2023 | 2 | 2023 |
| Richter's transformation in the heart A Marra, F Adamo, S Baldoni, ME Laurenti, M Giansanti, S Pasquino, ... The Lancet Oncology 22 (7), e341, 2021 | 2 | 2021 |
| Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY T Chatzikonstantinou, L Scarfò, G Karakatsoulis, E Minga, D Chamou, ... EClinicalMedicine 65, 2023 | 1 | 2023 |
| Real-world evidence on therapeutic strategies and treatment-sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research … T Chatzikonstantinou, L Scarfo, C Demosthenous, J Kotaskova, ... Blood 138 (Supplement 1), 2635-2635, 2021 | 1 | 2021 |
| S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY. T Chatzikonstantinou, L Scarfò, G Karakatsoulis, E Minga, D Chamou, ... HemaSphere 7, e24596f8, 2023 | | 2023 |
| Prediction of outcomes in cll patients treated with ibrutinib: validation of current prognostic models and development of a simplified three-factor model S Molica, D Giannarelli, A Visentin, G Reda, P Sportoletti, AM Frustaci, ... AMERICAN JOURNAL OF HEMATOLOGY, 2022 | | 2022 |
| Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia V Guarente, G Martino, E Dorillo, F De Falco, C Rompietti, D Sorcini, ... Frontiers in Oncology 11, 729106, 2021 | | 2021 |
| Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL. Cancers 2021, 13, 1280 V Guarente, P Sportoletti s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| BCOR AND DNMT3A LOSS COOPERATES IN THE PATHOGENESIS OF ACUTE ERYTHROID LEUKEMIA IN MICE P Sportoletti, D Sorcini, AG Guzman, JM Reyes, A Stella, A Marra, ... HAEMATOLOGICA 105, S23-S24, 2020 | | 2020 |
| NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES S Baldoni, B Del Papa, E Dorillo, F De Falco, C Rompietti, F Adamo, ... HAEMATOLOGICA 105, S30, 2020 | | 2020 |
| CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA EC SILVA BARCELOS, C Rompietti, B Del Papa, F De Falco, S Baldoni, ... HAEMATOLOGICA, 2020 | | 2020 |
| A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS B Del Papa, F De Falco, S Baldoni, E Dorillo, C Rompietti, F Adamo, ... HAEMATOLOGICA 105, S58, 2020 | | 2020 |
